Novo Nordisk
NVO
#19
Rank
A$739.50 B
Marketcap
$162.79
Share price
-0.40%
Change (1 day)
4.25%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

Number of shares outstanding for Novo Nordisk (NVO)

Number of shares outstanding as of November 2024 : 4,457,700,000

According to Novo Nordisk's latest financial reports and stock price the company's current number of shares outstanding is 4,457,700,000. At the end of 2024 the company had 4,457,700,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.

Shares outstanding history for Novo Nordisk from 2023 to 2024

Shares Outstanding at the end of each year

Year Shares Outstanding Change
20244.45 B-0.43%
20234.47 B

Shares Outstanding for similar companies or competitors

Company Shares Outstanding differencediff. Country
5,666,000,000 27.11%๐Ÿ‡บ๐Ÿ‡ธ USA
901,000,000-79.79%๐Ÿ‡บ๐Ÿ‡ธ USA
2,028,000,000-54.51%๐Ÿ‡บ๐Ÿ‡ธ USA
2,506,000,000-43.78%๐Ÿ‡ซ๐Ÿ‡ท France